Literature DB >> 19224106

Association study of clock gene (CLOCK) and schizophrenia and mood disorders in the Japanese population.

Taro Kishi1, Tsuyoshi Kitajima, Masashi Ikeda, Yoshio Yamanouchi, Yoko Kinoshita, Kunihiro Kawashima, Tomo Okochi, Takenori Okumura, Tomoko Tsunoka, Toshiya Inada, Norio Ozaki, Nakao Iwata.   

Abstract

Recently the clock genes have been reported to play some roles in neural transmitter systems, including the dopamine system, as well as to regulate circadian rhythms. Abnormalities in both of these mechanisms are thought to be involved in the pathophysiology of major mental illness such as schizophrenia and mood disorders including bipolar disorder (BP) and major depressive disorder (MDD). Recent genetic studies have reported that CLOCK, one of the clock genes, is associated with these psychiatric disorders. Therefore, we investigated the association between the six tagging SNPs in CLOCK and the risk of these psychiatric disorders in Japanese patients diagnosed with schizophrenia (733 patients), BP (149) and MDD (324), plus 795 Japanese controls. Only one association, with schizophrenia in females, was detected in the haplotype analysis (P = 0.0362). However, this significance did not remain after Bonferroni correction (P = 0.0724). No significant association was found with BP and MDD. In conclusion, we suggest that CLOCK may not play a major role in the pathophysiology of Japanese schizophrenia, BP and MDD patients. However, it will be important to replicate and confirm these findings in other independent studies using large samples.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19224106     DOI: 10.1007/s00406-009-0869-4

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  41 in total

1.  Genome-wide scans of three independent sets of 90 Irish multiplex schizophrenia families and follow-up of selected regions in all families provides evidence for multiple susceptibility genes.

Authors:  R E Straub; C J MacLean; Y Ma; B T Webb; M V Myakishev; C Harris-Kerr; B Wormley; H Sadek; B Kadambi; F A O'Neill; D Walsh; K S Kendler
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

2.  The future of association studies: gene-based analysis and replication.

Authors:  Benjamin M Neale; Pak C Sham
Journal:  Am J Hum Genet       Date:  2004-07-22       Impact factor: 11.025

3.  Autosomal linkage analysis of a Japanese single multiplex schizophrenia pedigree reveals two candidate loci on chromosomes 4q and 3q.

Authors:  Naoshi Kaneko; Tatsuyuki Muratake; Hideki Kuwabara; Takanori Kurosaki; Mitsuru Takei; Tsuyuka Ohtsuki; Tadao Arinami; Shoji Tsuji; Toshiyuki Someya
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-09-05       Impact factor: 3.568

Review 4.  Dissecting the genetic etiology of major depressive disorder using linkage analysis.

Authors:  Nicola J Camp; Lisa A Cannon-Albright
Journal:  Trends Mol Med       Date:  2005-03       Impact factor: 11.951

5.  Actimetric evidence that CLOCK 3111 T/C SNP influences sleep and activity patterns in patients affected by bipolar depression.

Authors:  Francesco Benedetti; Sara Dallaspezia; Mara Cigala Fulgosi; Cristina Lorenzi; Alessandro Serretti; Barbara Barbini; Cristina Colombo; Enrico Smeraldi
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-07-05       Impact factor: 3.568

Review 6.  Circadian genes, rhythms and the biology of mood disorders.

Authors:  Colleen A McClung
Journal:  Pharmacol Ther       Date:  2007-02-28       Impact factor: 12.310

Review 7.  Genetic models of schizophrenia and bipolar disorder: overlapping inheritance or discrete genotypes?

Authors:  Wolfgang Maier; Barbara Höfgen; Astrid Zobel; Marcella Rietschel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-06       Impact factor: 5.270

8.  Genetic studies of bipolar affective disorder in large families.

Authors:  D H Blackwood; P M Visscher; W J Muir
Journal:  Br J Psychiatry       Date:  2001-06       Impact factor: 9.319

9.  Regulation of monoamine oxidase A by circadian-clock components implies clock influence on mood.

Authors:  Gabriele Hampp; Jürgen A Ripperger; Thijs Houben; Isabelle Schmutz; Christian Blex; Stéphanie Perreau-Lenz; Irene Brunk; Rainer Spanagel; Gudrun Ahnert-Hilger; Johanna H Meijer; Urs Albrecht
Journal:  Curr Biol       Date:  2008-04-24       Impact factor: 10.834

10.  Mania-like behavior induced by disruption of CLOCK.

Authors:  Kole Roybal; David Theobold; Ami Graham; Jennifer A DiNieri; Scott J Russo; Vaishnav Krishnan; Sumana Chakravarty; Joseph Peevey; Nathan Oehrlein; Shari Birnbaum; Martha H Vitaterna; Paul Orsulak; Joseph S Takahashi; Eric J Nestler; William A Carlezon; Colleen A McClung
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-22       Impact factor: 11.205

View more
  23 in total

Review 1.  The role of sleep problems and circadian clock genes in childhood psychiatric disorders.

Authors:  Alexander Dueck; Johannes Thome; Frank Haessler
Journal:  J Neural Transm (Vienna)       Date:  2012-06-06       Impact factor: 3.575

Review 2.  Circadian rhythms and mood regulation: insights from pre-clinical models.

Authors:  Colleen A McClung
Journal:  Eur Neuropsychopharmacol       Date:  2011-08-11       Impact factor: 4.600

Review 3.  Clock gene variants in mood and anxiety disorders.

Authors:  Timo Partonen
Journal:  J Neural Transm (Vienna)       Date:  2012-04-27       Impact factor: 3.575

4.  Case-control association study for 10 genes in patients with schizophrenia: influence of 5HTR1A variation rs10042486 on schizophrenia and response to antipsychotics.

Authors:  Concetta Crisafulli; Alberto Chiesa; Changsu Han; Soo-Jung Lee; Moon Ho Park; Beatrice Balzarro; Costanza Andrisano; Ashwin A Patkar; Chi-Un Pae; Alessandro Serretti
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-11-27       Impact factor: 5.270

5.  Lack of association between MAGEL2 and schizophrenia and mood disorders in the Japanese population.

Authors:  Yasuhisa Fukuo; Taro Kishi; Tomo Okochi; Tsuyoshi Kitajima; Tomoko Tsunoka; Takenori Okumukura; Yoko Kinoshita; Kunihiro Kawashima; Yoshio Yamanouchi; Wakako Umene-Nakano; Hiroshi Naitoh; Toshiya Inada; Reiji Yoshimura; Jun Nakamura; Norio Ozaki; Nakao Iwata
Journal:  Neuromolecular Med       Date:  2010-05-14       Impact factor: 3.843

6.  No association between polymorphisms of neuronal oxide synthase 1 gene (NOS1) and schizophrenia in a Japanese population.

Authors:  Takenori Okumura; Tomo Okochi; Taro Kishi; Masashi Ikeda; Tsuyoshi Kitajima; Yoshio Yamanouchi; Yoko Kinoshita; Kunihiro Kawashima; Tomoko Tsunoka; Hiroshi Ujike; Toshiya Inada; Norio Ozaki; Nakao Iwata
Journal:  Neuromolecular Med       Date:  2009-06-10       Impact factor: 3.843

7.  ARNTL (BMAL1) and NPAS2 gene variants contribute to fertility and seasonality.

Authors:  Leena Kovanen; Sirkku T Saarikoski; Arpo Aromaa; Jouko Lönnqvist; Timo Partonen
Journal:  PLoS One       Date:  2010-04-02       Impact factor: 3.240

8.  HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort.

Authors:  Taro Kishi; Reiji Yoshimura; Tsuyoshi Kitajima; Tomo Okochi; Takenori Okumura; Tomoko Tsunoka; Yoshio Yamanouchi; Yoko Kinoshita; Kunihiro Kawashima; Hiroshi Naitoh; Jun Nakamura; Norio Ozaki; Nakao Iwata
Journal:  Neuromolecular Med       Date:  2009-11-24       Impact factor: 3.843

9.  Translin-associated factor X gene (TSNAX) may be associated with female major depressive disorder in the Japanese population.

Authors:  Akiko Okuda; Taro Kishi; Tomo Okochi; Masashi Ikeda; Tsuyoshi Kitajima; Tomoko Tsunoka; Takenori Okumukura; Yasuhisa Fukuo; Yoko Kinoshita; Kunihiro Kawashima; Yoshio Yamanouchi; Toshiya Inada; Norio Ozaki; Nakao Iwata
Journal:  Neuromolecular Med       Date:  2009-09-04       Impact factor: 3.843

10.  CLOCK may predict the response to fluvoxamine treatment in Japanese major depressive disorder patients.

Authors:  Taro Kishi; Tsuyoshi Kitajima; Masashi Ikeda; Yoshio Yamanouchi; Yoko Kinoshita; Kunihiro Kawashima; Tomo Okochi; Takenori Okumura; Tomoko Tsunoka; Norio Ozaki; Nakao Iwata
Journal:  Neuromolecular Med       Date:  2009-04-04       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.